HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $338K invested in Hepion Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$128K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$19.6K |
| 3 |
Renaissance Technologies
New York
|
+$11.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$703 |
